
Fasikl is a Neuro-AI company based in Minnesota, dedicated to developing innovative AI therapies that provide patients and physicians with a new, more effective, safer, and personalized approach to treating diseases. Their flagship product, the Felix™ NeuroAI™ Wristband, is the world's first AI-powered wearable that non-invasively modulates the nervous system to reduce essential tremors, offering continuous, all-day relief. Built on patented technologies, Fasikl's platform integrates NeuroAI algorithms to enhance existing neuromodulation therapies, leading the way into the era of AI therapeutics. The company has demonstrated significant clinical outcomes through rigorous trials, positioning itself as a leader in AI-driven therapeutic technologies.

Fasikl is a Neuro-AI company based in Minnesota, dedicated to developing innovative AI therapies that provide patients and physicians with a new, more effective, safer, and personalized approach to treating diseases. Their flagship product, the Felix™ NeuroAI™ Wristband, is the world's first AI-powered wearable that non-invasively modulates the nervous system to reduce essential tremors, offering continuous, all-day relief. Built on patented technologies, Fasikl's platform integrates NeuroAI algorithms to enhance existing neuromodulation therapies, leading the way into the era of AI therapeutics. The company has demonstrated significant clinical outcomes through rigorous trials, positioning itself as a leader in AI-driven therapeutic technologies.
Headquarters & focus: Minneapolis/Bloomington, MN-based Neuro-AI company building AI-driven wearable therapeutics
Flagship product: Felix NeuroAI Wristband — noninvasive AI-powered wearable for essential tremor
Regulatory milestone: U.S. FDA 510(k) clearance for Felix NeuroAI Wristband
Founding: Founded 2019 as a university spin-off
Funding: Multiple rounds including Series A/A+; reported total funding ~$59.86M (USD)
Treatment of essential tremor and development of AI therapeutics for neuromodulation
2019
Biotechnology
$5,000,000
Company-reported Pre-A financing
$10,000,000
Company-reported Series A financing
$18,300,000
Company-reported A+ round co-led by iSeed and Tailwind
Most recent funding date recorded in company snapshot
“iSeed Ventures; Tailwind Ventures; Qiming Venture Partners”